• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

让疟疾诊断和治疗更贴近民众:在马达加斯加一个农村地区将疟疾社区病例管理扩展至所有年龄段的经济合理性

Bringing malaria diagnosis and treatment closer to the people: economic rationale for expanding malaria community case management to all ages in a rural district in Madagascar.

作者信息

Ochieng Walter, Gutman Julie R, Dentinger Catherine, Harimanana Aina, Irinantenaina Judickaelle, Razanadranaivo Hobisoa Léa, Raobela Oméga, Mukerabirori Aline, Kapesa Laurent, Garchitorena Andres, Steinhardt Laura

机构信息

Global Health Center, US Centers for Disease Control and Prevention, Atlanta, GA, USA.

National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA.

出版信息

Malar J. 2025 May 4;24(1):141. doi: 10.1186/s12936-025-05381-y.

DOI:10.1186/s12936-025-05381-y
PMID:40320532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12049781/
Abstract

BACKGROUND

Expanding malaria community case management (mCCM) to all ages could shift the point-of-care to the community leading to improved healthcare access in underserved populations. This study assesses the economic viability of such an expansion in Farafangana district, Madagascar.

METHODS

A cluster-randomized trial was conducted across 30 health centres and the 502 community health workers (CHW) in their catchment areas, with the intervention arm implementing the age-expanded mCCM intervention. CHWs across both arms received training, supplies, and supervision to manage malaria. An economic evaluation assessed cost-effectiveness from health sector and societal perspectives, measuring outcomes in disability-adjusted life years (DALYs) averted. The impact of CHW compensation and economic risks were evaluated using sensitivity analyses.

RESULTS

Without CHW compensation, annual costs were $794,000, primarily for antimalarials and diagnostic tests. Incremental cost-effectiveness ratios (ICERs) per DALY averted ranged from -$21.86 to $212.42. From a societal perspective, the ICER was -$135.64, and -$243.29 including mortality benefits, meaning the intervention was cost-saving. The programme could avert 99.6 deaths and 3,721.7 DALYs annually, yielding $1,172,283 in net economic benefits. Sensitivity analyses supported these findings.

CONCLUSIONS

Age-expanded mCCM is highly cost-effective and can enhance malaria treatment access in resource-limited settings.

摘要

背景

将疟疾社区病例管理(mCCM)扩展至所有年龄段,可将医疗服务点转移至社区,从而改善服务不足人群的医疗保健可及性。本研究评估了在马达加斯加法拉方加纳区进行此类扩展的经济可行性。

方法

在30个卫生中心及其服务区域内的502名社区卫生工作者(CHW)中开展了一项整群随机试验,干预组实施年龄扩展的mCCM干预措施。两组的社区卫生工作者均接受了管理疟疾的培训、物资供应和监督。一项经济评估从卫生部门和社会角度评估了成本效益,以避免的伤残调整生命年(DALY)衡量结果。使用敏感性分析评估了社区卫生工作者薪酬和经济风险的影响。

结果

在没有社区卫生工作者薪酬的情况下,年度成本为79.4万美元,主要用于抗疟药物和诊断检测。每避免一个DALY的增量成本效益比(ICER)在-21.86美元至212.42美元之间。从社会角度来看,ICER为-135.64美元,包括死亡效益在内为-243.29美元,这意味着该干预措施具有成本节约效益。该项目每年可避免99.6例死亡和3721.7个DALY,产生1172283美元的净经济效益。敏感性分析支持了这些结果。

结论

年龄扩展的mCCM具有很高的成本效益,可在资源有限的环境中增加疟疾治疗的可及性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4360/12049781/029a751f8810/12936_2025_5381_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4360/12049781/6e8a4189fa9f/12936_2025_5381_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4360/12049781/74389df74731/12936_2025_5381_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4360/12049781/029a751f8810/12936_2025_5381_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4360/12049781/6e8a4189fa9f/12936_2025_5381_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4360/12049781/74389df74731/12936_2025_5381_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4360/12049781/029a751f8810/12936_2025_5381_Fig3_HTML.jpg

相似文献

1
Bringing malaria diagnosis and treatment closer to the people: economic rationale for expanding malaria community case management to all ages in a rural district in Madagascar.让疟疾诊断和治疗更贴近民众:在马达加斯加一个农村地区将疟疾社区病例管理扩展至所有年龄段的经济合理性
Malar J. 2025 May 4;24(1):141. doi: 10.1186/s12936-025-05381-y.
2
Expanding community case management of malaria to all ages can improve universal access to malaria diagnosis and treatment: results from a cluster randomized trial in Madagascar.扩大疟疾社区病例管理范围至全年龄段可提高疟疾诊断和治疗的普及性:来自马达加斯加的一项集群随机试验结果。
BMC Med. 2024 Jun 10;22(1):231. doi: 10.1186/s12916-024-03441-9.
3
Cost-effectiveness analysis of malaria rapid diagnostic tests for appropriate treatment of malaria at the community level in Uganda.乌干达社区层面疟疾快速诊断检测用于疟疾适当治疗的成本效益分析
Health Policy Plan. 2017 Jun 1;32(5):676-689. doi: 10.1093/heapol/czw171.
4
Baseline malaria prevalence and care-seeking behaviours in rural Madagascar prior to a trial to expand malaria community case management to all ages.马达加斯加农村在扩大疟疾社区病例管理至所有年龄段的试验之前的基线疟疾流行率和求医行为。
Malar J. 2021 Oct 26;20(1):422. doi: 10.1186/s12936-021-03956-z.
5
The 1,7-malaria reactive community-based testing and response (1,7-mRCTR) approach in Tanzania: a cost-effectiveness analysis.坦桑尼亚基于社区的1,7疟疾反应性检测与应对(1,7-mRCTR)方法:成本效益分析
Infect Dis Poverty. 2024 Dec 4;13(1):92. doi: 10.1186/s40249-024-01261-w.
6
Cost-effectiveness of malaria control in sub-Saharan Africa.撒哈拉以南非洲地区疟疾防控的成本效益
Lancet. 1999 Jul 31;354(9176):378-85. doi: 10.1016/s0140-6736(99)02141-8.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya.通过基于诊断的补贴来改善抗疟药的合理使用:来自肯尼亚西部一项集群随机对照试验的证据。
PLoS Med. 2018 Jul 17;15(7):e1002607. doi: 10.1371/journal.pmed.1002607. eCollection 2018 Jul.
9
Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.季节性间歇性预防治疗使用阿莫地喹和青蒿琥酯或磺胺多辛-乙胺嘧啶在加纳儿童中的成本效益。
PLoS One. 2010 Aug 17;5(8):e12223. doi: 10.1371/journal.pone.0012223.
10
Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis.转诊前直肠青蒿琥酯治疗儿童重症疟疾:成本效益分析。
Lancet. 2010 Dec 4;376(9756):1910-5. doi: 10.1016/S0140-6736(10)61460-2. Epub 2010 Nov 29.

本文引用的文献

1
Expanding community case management of malaria to all ages can improve universal access to malaria diagnosis and treatment: results from a cluster randomized trial in Madagascar.扩大疟疾社区病例管理范围至全年龄段可提高疟疾诊断和治疗的普及性:来自马达加斯加的一项集群随机试验结果。
BMC Med. 2024 Jun 10;22(1):231. doi: 10.1186/s12916-024-03441-9.
2
Estimating the burden of severe malarial anaemia and access to hospital care in East Africa.估算东非严重疟疾贫血症的负担和获得医院治疗的情况。
Nat Commun. 2023 Sep 14;14(1):5691. doi: 10.1038/s41467-023-41275-w.
3
Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures.
确定实现全民健康覆盖的效率路径:基于预期寿命和卫生支出增长的 174 个国家的成本效益阈值。
Lancet Glob Health. 2023 Jun;11(6):e833-e842. doi: 10.1016/S2214-109X(23)00162-6.
4
Geographic barriers to care persist at the community healthcare level: Evidence from rural Madagascar.社区医疗层面存在医疗服务的地理障碍:来自马达加斯加农村的证据。
PLOS Glob Public Health. 2022 Dec 27;2(12):e0001028. doi: 10.1371/journal.pgph.0001028. eCollection 2022.
5
Effectiveness of community case management of malaria on severe malaria and inpatient malaria deaths in Zambia: a dose-response study using routine health information system data.赞比亚利用常规卫生信息系统数据进行的一项剂量反应研究:以疟疾社区病例管理对严重疟疾和住院疟疾死亡的影响
Malar J. 2023 Mar 17;22(1):96. doi: 10.1186/s12936-023-04525-2.
6
The Use of Cost-Effectiveness Thresholds for Evaluating Health Interventions in Low- and Middle-Income Countries From 2015 to 2020: A Review.2015 年至 2020 年期间,用于评估中低收入国家卫生干预措施的成本效益阈值:综述。
Value Health. 2022 Mar;25(3):385-389. doi: 10.1016/j.jval.2021.08.014. Epub 2021 Oct 29.
7
Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches.成本效益风险规避曲线:风险调整绩效衡量指标与期望效用方法的比较。
Pharmacoeconomics. 2022 May;40(5):497-507. doi: 10.1007/s40273-021-01123-5. Epub 2022 Feb 9.
8
Handling Uncertainty in Cost-Effectiveness Analysis: Budget Impact and Risk Aversion.成本效益分析中的不确定性处理:预算影响与风险规避。
Healthcare (Basel). 2021 Oct 22;9(11):1419. doi: 10.3390/healthcare9111419.
9
Introduction to the Special Issue on "The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update".关于“世界卫生组织选择具有成本效益的干预措施(WHO-CHOICE)更新”特刊的介绍。
Int J Health Policy Manag. 2021 Nov 1;10(11):670-672. doi: 10.34172/ijhpm.2021.105.
10
Integrated community case management of childhood illness in low- and middle-income countries.低收入和中等收入国家儿童疾病的综合社区病例管理
Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD012882. doi: 10.1002/14651858.CD012882.pub2.